Biohaven VP and CAO reports 17,000-share BHVN insider purchase

Rhea-AI Filing Summary

Biohaven Ltd. officer reports open-market share purchase. A vice president and Chief Accounting Officer of Biohaven Ltd. (BHVN) bought 17,000 common shares on 11/17/2025 at a weighted average price of $8.5159 per share through a series of trades within a narrow price range. After this transaction, the insider beneficially owns 20,000 common shares indirectly through an IRA and 65,595 shares directly, for a combined personal stake in the company that includes 544 shares acquired under the employee share purchase plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clark George C.

(Last) (First) (Middle)

C/O BIOHAVEN LTD.

215 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Biohaven Ltd. [ BHVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/17/2025		P		17,000	A	$8.5159(1)	20,000	I	By IRA
Common Shares								65,595(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4950 - $8.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

2. This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan (the "ESPP") on May 31, 2025.

Remarks:

	/s/ George Clark	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Biohaven (BHVN) report in this Form 4?

A Biohaven vice president and Chief Accounting Officer reported buying 17,000 common shares of BHVN on 11/17/2025 in an open-market transaction.

At what price were the Biohaven (BHVN) shares purchased in the Form 4?

The 17,000 Biohaven common shares were bought at a weighted average price of $8.5159 per share, with individual trade prices ranging from $8.4950 to $8.5200.

How many Biohaven (BHVN) shares does the reporting officer own after this transaction?

Following the transaction, the officer beneficially owns 20,000 Biohaven common shares indirectly through an IRA and 65,595 common shares directly.

Does the Form 4 mention shares acquired through a Biohaven employee plan?

Yes. The directly owned balance of 65,595 shares includes 544 shares acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.

What is the relationship of the reporting person to Biohaven (BHVN)?

The reporting person is an officer of Biohaven Ltd., serving as Vice President and Chief Accounting Officer, and is required to report transactions under Section 16 rules.

Is the Biohaven (BHVN) Form 4 filed by more than one reporting person?

No. The filing is indicated as being filed by one reporting person, not a group or joint filing.